Showing results (81-90 of 230) with videos related to

Sort By:
Pageof 23
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 26, 2017
Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS)Lisette Okkels Jensen, Saila Vikman, Lisbeth Antonsen, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 22, 2010
IVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus-eluting device during the bioabsorption processGiovanna Sarno, Yoshinobu Onuma, Hector M Garcia Garcia, et al.
Journal of Thrombosis and Thrombolysis|June 28, 2014
Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trialsGiuseppe De Luca, Maurits T Dirksen, Henning Kelbæk, et al.
Clinical Epidemiology|September 27, 2013
Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiologyLeif Thuesen, Lisette Okkels Jensen, Hans Henrik Tilsted, et al.
The American Journal of Cardiology|December 5, 2019
Ten-Year Outcomes of Sirolimus-Eluting Versus Zotarolimus-Eluting Coronary Stents in Patients With Versus Without Diabetes Mellitus (SORT OUT III)Kevin K W Olesen, Manan Pareek, Morten Madsen, et al.
The American Journal of Cardiology|July 16, 2011
System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial)Peter H Nielsen, Christian J Terkelsen, Torsten T Nielsen, et al.
European Heart Journal|October 25, 2007
The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-upMartin Busk, Michael Maeng, Klaus Rasmussen, et al.
Heart (British Cardiac Society)|January 22, 2013
Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart diseaseAziza Azimi, Mette Gitz Charlot, Christian Torp-Pedersen, et al.
European Journal of Preventive Cardiology|July 5, 2011
No gender differences in prognosis and preventive treatment in patients with AMI without significant stenosesKim Wadt Hansen, Anders Hvelplund, Steen Zabell Abildstrøm, et al.
Circulation. Cardiovascular Interventions|April 10, 2014
Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trialPer Thayssen, Jens Flensted Lassen, Svend Eggert Jensen, et al.
Pageof 23